(Q36425917)

14 August 2017

1 reference

title

T regulatory cells as an immunotherapy for transplantation (English)

1 reference

14 August 2017

1 reference

Michael H Albert

1

1 reference

14 August 2017

Claudio Anasetti

series ordinal

2

1 reference

14 August 2017

Xue-Zhong Yu

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

Expert Opinion on Biological Therapy

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

4

1 reference

14 August 2017

315-324

1 reference

Advances in transplantation tolerance

14 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Regulatory T cells in transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

The complementary roles of deletion and regulation in transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Prevention of lethal acute GVHD with an agonistic CD28 antibody and rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

"Infectious" transplantation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Requirement for natural killer T (NKT) cells in the induction of allograft tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Immunopathology of interleukin (IL) 2-deficient mice: thymus dependence and suppression by thymus-dependent cells with an intact IL-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

A function for interleukin 2 in Foxp3-expressing regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

An essential role for Scurfin in CD4+CD25+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Natural versus adaptive regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Differentiation of T regulatory cells by immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Association of Foxp3 regulatory gene expression with graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Regulatory T-cell therapy: is it ready for the clinic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Classical transplantation tolerance in the adult: the interaction between myeloablation and immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Identification of regulatory T cells in tolerated allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Alloreactive T cell responses and acute rejection of single class II MHC-disparate heart allografts are under strict regulation by CD4+ CD25+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Donor-specific transplantation tolerance: the paradoxical behavior of CD4+CD25+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Specificity of CD4+CD25+ regulatory T cell function in alloimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Regulatory T cells, derived from naïve CD4+CD25- T cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

T cell death and transplantation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Everolimus and basiliximab permit suppression by human CD4+CD25+ cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.4.315

21 January 2018

Identifiers

DOI

10.1517/14712598.6.4.315

1 reference

14 August 2017

1 reference